Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Pseudohyperkalemia Cardiff
|
60 | 0.667 | 0.400 | 20 | 3213196 | missense variant | C/A;G | snv | 7.5E-02 | 0.010 | 1.000 | 1 | 2019 | 2019 | |||||
Pancreatitis
|
80 | 0.667 | 0.400 | 20 | 3213196 | missense variant | C/A;G | snv | 7.5E-02 | 0.010 | 1.000 | 1 | 2011 | 2011 | |||||
Lupus Erythematosus, Systemic
|
1172 | 0.667 | 0.400 | 20 | 3213196 | missense variant | C/A;G | snv | 7.5E-02 | 0.030 | 1.000 | 3 | 2009 | 2012 | |||||
Liver Cirrhosis
|
189 | 0.667 | 0.400 | 20 | 3213196 | missense variant | C/A;G | snv | 7.5E-02 | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||
Leukopenia
|
153 | 0.667 | 0.400 | 20 | 3213196 | missense variant | C/A;G | snv | 7.5E-02 | 0.020 | 1.000 | 2 | 2006 | 2015 | |||||
Leukemia, Myelocytic, Acute
|
6892 | 0.667 | 0.400 | 20 | 3213196 | missense variant | C/A;G | snv | 7.5E-02 | 0.010 | 1.000 | 1 | 2013 | 2013 | |||||
Juvenile arthritis
|
128 | 0.667 | 0.400 | 20 | 3213196 | missense variant | C/A;G | snv | 7.5E-02 | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||
Inosine Triphosphatase Deficiency
|
4 | 0.667 | 0.400 | 20 | 3213196 | missense variant | C/A;G | snv | 7.5E-02 | 0.700 | 0 | ||||||||
Influenza-like symptoms
|
4 | 0.667 | 0.400 | 20 | 3213196 | missense variant | C/A;G | snv | 7.5E-02 | 0.020 | 1.000 | 2 | 2008 | 2011 | |||||
Inflammatory Bowel Diseases
|
605 | 0.667 | 0.400 | 20 | 3213196 | missense variant | C/A;G | snv | 7.5E-02 | 0.010 | 1.000 | 1 | 2006 | 2006 | |||||
Hepatitis C, Chronic
|
80 | 0.667 | 0.400 | 20 | 3213196 | missense variant | C/A;G | snv | 7.5E-02 | 0.850 | 0.833 | 6 | 2010 | 2020 | |||||
Hepatitis C
|
347 | 0.667 | 0.400 | 20 | 3213196 | missense variant | C/A;G | snv | 7.5E-02 | 0.100 | 0.900 | 10 | 2011 | 2018 | |||||
Hepatitis A
|
27 | 0.667 | 0.400 | 20 | 3213196 | missense variant | C/A;G | snv | 7.5E-02 | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||
Hepatitis
|
42 | 0.667 | 0.400 | 20 | 3213196 | missense variant | C/A;G | snv | 7.5E-02 | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||
Fibrosis, Liver
|
64 | 0.667 | 0.400 | 20 | 3213196 | missense variant | C/A;G | snv | 7.5E-02 | 0.010 | 1 | 2017 | 2017 | ||||||
Febrile Neutropenia
|
14 | 0.667 | 0.400 | 20 | 3213196 | missense variant | C/A;G | snv | 7.5E-02 | 0.010 | 1.000 | 1 | 2010 | 2010 | |||||
Coinfection
|
11 | 0.667 | 0.400 | 20 | 3213196 | missense variant | C/A;G | snv | 7.5E-02 | 0.010 | 1.000 | 1 | 2011 | 2011 | |||||
Cirrhosis
|
110 | 0.667 | 0.400 | 20 | 3213196 | missense variant | C/A;G | snv | 7.5E-02 | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||
Childhood Acute Lymphoblastic Leukemia
|
261 | 0.667 | 0.400 | 20 | 3213196 | missense variant | C/A;G | snv | 7.5E-02 | 0.020 | 1.000 | 2 | 2010 | 2015 | |||||
Bone Marrow Suppression
|
2 | 0.667 | 0.400 | 20 | 3213196 | missense variant | C/A;G | snv | 7.5E-02 | 0.010 | 1.000 | 1 | 2009 | 2009 | |||||
Anemia, severe
|
6 | 0.667 | 0.400 | 20 | 3213196 | missense variant | C/A;G | snv | 7.5E-02 | 0.020 | 1.000 | 2 | 2013 | 2019 | |||||
Anemia, Hemolytic
|
31 | 0.667 | 0.400 | 20 | 3213196 | missense variant | C/A;G | snv | 7.5E-02 | 0.040 | 0.750 | 4 | 2012 | 2017 | |||||
Anemia
|
94 | 0.667 | 0.400 | 20 | 3213196 | missense variant | C/A;G | snv | 7.5E-02 | 0.900 | 0.900 | 20 | 2010 | 2020 | |||||
Agranulocytosis
|
8 | 0.667 | 0.400 | 20 | 3213196 | missense variant | C/A;G | snv | 7.5E-02 | 0.010 | 1.000 | 1 | 2009 | 2009 | |||||
Adult Acute Lymphocytic Leukemia
|
154 | 0.667 | 0.400 | 20 | 3213196 | missense variant | C/A;G | snv | 7.5E-02 | 0.020 | 1.000 | 2 | 2010 | 2015 |